During the past decade, Ospedale Campo di Marte conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Campo di Marte" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored, "Azienda Ospedaliero, Universitaria Pisana" with 1 trials sponsored, "Gruppo di Ricerca GISSI" with 1 trials sponsored and "Heart Care Foundation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Campo di Marte" #1 collaborator was "Aventis Pharmaceuticals" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 1 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 1 trials as a collaborator and "Gruppo Oncologico del Nord-Ovest" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Campo di Marte" are "Acute Myocardial Infarction" (1 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials), "Adenocarcinoma of the Stomach" (1 trials), "Atrial Fibrillation" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Ospedale Campo di Marte" in a lesser frequency.

Most popular intervention types in "Ospedale Campo di Marte" are "Drug" (5 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cholecystectomy" (1 trials), "Cyclosporine A" (1 trials), "Empagliflozin" (1 trials) and "Irinotecan, Leucovorin, 5-Fluorouracil, Docetaxel, Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Campo di Marte" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Campo di Marte". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ospedale Campo di Marte, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Campo di Marte, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".